Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Randomized Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of a Single Infusion of Bezlotoxumab MK 6072 Human Monoclonal Antibody to C difficile Toxin B in Children Aged 1 to 18...

1 To characterize bezlotoxumab PK in 2 age cohorts Age Cohort 1: 12 to 18 years Age Cohort 2: 1 to 12 years of pediatric participants to support dose selection in this population 2To evaluate the safety and tolerability of a single infusion of bezlotoxumab as compared with a single infusion of placebo through 12 weeks following infusion

FieldValue
Modified
2020-01-25
Release Date
2018-07-21
Identifier
0553b66c-753f-4770-9c5b-6ca04f2843fb
License
Public Access Level
Public